Julien Jorda serves as the Principal Scientist and Head of Computational Biology at Pythia, where he plays a pivotal role in advancing the intersection of artificial intelligence and drug development. With over seven years of experience, Julien specializes in AI-based hit identification, focusing on the...
Julien Jorda serves as the Principal Scientist and Head of Computational Biology at Pythia, where he plays a pivotal role in advancing the intersection of artificial intelligence and drug development. With over seven years of experience, Julien specializes in AI-based hit identification, focusing on the design and optimization of protein binder candidates. His leadership is instrumental in steering key projects that leverage Pythia's cutting-edge AI models to uncover novel therapeutic targets and streamline the drug discovery process.
At Pythia, Julien leads a dynamic team that is dedicated to developing the foundational biological insights necessary for enhancing AI-driven therapeutic solutions. His work involves a comprehensive analysis of biological data, employing advanced bioinformatics techniques and molecular modeling to inform and refine the AI algorithms that underpin Pythia's innovative drug development strategies. By fostering a collaborative and inclusive work environment, Julien ensures that his team thrives, encouraging open communication and the sharing of ideas that drive scientific discovery.
Julien's expertise extends to a diverse array of technical skills, including proficiency in TensorFlow for machine learning applications, as well as programming languages such as C++ and PHP, which facilitate the development of robust computational tools. His commitment to integrating cloud computing solutions further enhances the scalability and efficiency of Pythia's research initiatives. Through his strategic vision and hands-on leadership, Julien Jorda is not only shaping the future of drug development at Pythia but also contributing to the broader field of computational biology.
